It must also be noted that certain agents (namely ACE inhibitors and sartans) are prescribed to CKD patients even in the absence of hypertension to prevent further decline in eGFR (Ruggenenti et al. 2012), and this might influence results obtained by studies using the database of antihypertensive prescriptions as a proxy of a diagnosis of hypertension. This evidence concerns the gene ACE and hypertensive disorder.